Jäntti, Henna, Oksanen, Minna, Kettunen, Pinja, Manta, Stella, Mouledous, Lionel, Koivisto, Hennariikka, Ruuth, Johanna, Trontti, Kalevi, Dhungana, Hiramani, Keuters, Meike, Weert, Isabelle, Koskuvi, Marja, Hovatta, Iiris, Linden, Anni-Maija, Rampon, Claire, Malm, Tarja, Tanila, Heikki, Koistinaho, Jari, and Rolova, Taisia
The PSEN1 ΔE9 mutation causes a familial form of Alzheimer's disease (AD) by shifting the processing of amyloid precursor protein (APP) towards the generation of highly amyloidogenic Aβ42 peptide. We have previously shown that the PSEN1 ΔE9 mutation in human-induced pluripotent stem cell (iPSC)-derived astrocytes increases Aβ42 production and impairs cellular responses. Here, we injected PSEN1 ΔE9 mutant astrosphere-derived glial progenitors into newborn mice and investigated mouse behavior at the ages of 8, 12, and 16 months. While we did not find significant behavioral changes in younger mice, spatial learning and memory were paradoxically improved in 16-month-old PSEN1 ΔE9 glia-transplanted male mice as compared to age-matched isogenic control-transplanted animals. Memory improvement was associated with lower levels of soluble, but not insoluble, human Aβ42 in the mouse brain. We also found a decreased engraftment of PSEN1 ΔE9 mutant cells in the cingulate cortex and significant transcriptional changes in both human and mouse genes in the hippocampus, including the extracellular matrix-related genes. Overall, the presence of PSEN1 ΔE9 mutant glia exerted a more beneficial effect on aged mouse brain than the isogenic control human cells likely as a combination of several factors. [ABSTRACT FROM AUTHOR]